tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

LivaNova upgraded to Outperform from Peer Perform at Wolfe Research

Wolfe Research upgraded LivaNova (LIVN) to Outperform from Peer Perform with a $60 price target The firm says that since its downgrade, LivaNova’s valuation has compressed, its Italian legal overhang has lifted at a total liability a little less than “worst case,” and it made a commitment to expand oxygenator capacity into next year, which could produce “step change” in its ability to supply 2026. In addition, management recently sounded “cautiously more-optimistic-than-expected” on the pathway with Medicare for depression, the analyst tells investors in a research note.

Elevate Your Investing Strategy:

  • Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Disclaimer & DisclosureReport an Issue

1